Quantitative Investment Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Quantitative Investment Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-17,363	Closed	-$428K	–	702
2020 Q4	$428K	Sell	17,363 -13,762	-44%	-$456K	0.03%	357
2020 Q3	$1.29M	Buy	+31,125	New	+$1.43M	0.11%	158
2020 Q2	–	Sell	-33,878	Closed	-$2.13M	–	725
2020 Q1	$2.13M	Buy	+33,878	New	+$3.04M	0.23%	109
2018 Q3	–	Sell	-5,600	Closed	-$469K	–	935
2018 Q2	$469K	Sell	5,600 -36,100	-87%	-$2.64M	0.01%	613
2018 Q1	$2.56M	Buy	+41,700	New	+$2.51M	0.04%	406
2017 Q3	–	Sell	-30,800	Closed	-$3.73M	–	879
2017 Q2	$3.73M	Buy	+30,800	New	+$3.57M	0.06%	392
2016 Q4	–	Sell	-19,200	Closed	-$3.16M	–	988
2016 Q3	$3.16M	Buy	+19,200	New	+$3.03M	0.1%	233
2016 Q2	–	Sell	-4,800	Closed	-$616K	–	970
2016 Q1	$616K	Buy	+4,800	New	+$567K	0.03%	508
2015 Q2	–	Sell	-5,500	Closed	-$1.55M	–	732
2015 Q1	$1.55M	Buy	+5,500	New	+$1.19M	0.15%	127

Other funds holding ICPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Quantitative Investment Management's ICPT Position: Q1 2021 in Review

Quantitative Investment Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2021, closing a stake of 17,363 shares — an estimated $428K sold.

Quantitative Investment Management first reported a position in ICPT in Q1 2015 and held it in 9 quarters. The position peaked at $3.73M in Q2 2017. 151 funds tracked by Wall St. Rank hold ICPT as of Q1 2021.

Quantitative Investment Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2021 after selling out during the quarter.
Quantitative Investment Management sold 17,363 Intercept Pharmaceuticals, Inc. shares in Q1 2021, an estimated $428K.
Quantitative Investment Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 9 quarters.
Quantitative Investment Management's Intercept Pharmaceuticals, Inc. position peaked at $3.73M in Q2 2017.
151 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2021.

Based on Quantitative Investment Management's 13F filing for Q1 2021, filed 17 May 2021.